James Walsh

Reporter | Medical Technology
Phone: 612-673-7428
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.

Recent content from James Walsh

Litigation takes a bite out of profit at Medtronic

The company estimated legal costs of $245 million, depressing earnings by 26 percent.

Updated: November 20, 2012, - 09:38 PM

MOA to expand restrictions on teens during holiday shopping season

Unaccompanied teens won't be allowed on Thanksgiving, Black Friday.

Updated: November 17, 2012, - 10:19 PM

St. Jude Medical's job cuts may pay off

The key is making sure the cuts don't infringe on research and development, experts say.

Updated: November 02, 2012, - 08:30 PM

St. Jude Medical cutting 500 jobs in another round of layoffs

Med-tech company laid off 300 people in August.

Updated: November 02, 2012, - 12:03 AM

Boston Sci's new CEO has products in pipeline

As Mike Mahoney assumes the reins as CEO of Boston Scientific Corp., he does so with lots of innovation on tap for many years ahead.

Updated: November 01, 2012, - 08:57 PM

Study results are mixed for St. Jude anti-stroke heart plug

Market analysts and the company say the device's benefits still are promising.

Updated: October 29, 2012, - 09:15 PM

Maker of Flexitouch expanding

Tactile Systems, which makes a device to manage lymphedema, will address other conditions and launch international sales.

Updated: October 27, 2012, - 04:59 PM

Medtronic's pull influenced Infuse articles, report finds

Med-tech firm disputes U.S. Senate panel's findings.

Updated: October 25, 2012, - 10:48 PM

Medtronic touts results of heart valve procedure

Study shows low mortality at one year for people who have valves replaced via catheter.

Updated: October 22, 2012, - 08:28 PM

St. Jude device takes on migraines

St. Jude Medical's pacemaker-like device gives some relief to those with chronic pain. It's approved in Europe, but not yet in the United States.

Updated: October 20, 2012, - 09:39 PM

Result Per Page

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT